Trinckauf H H
Z Urol Nephrol. 1977 Jun;70(6):385-9.
Examinations of 69 patients with teratoid tumours of the testicles who underwent the expanded operative and cytostatic treatment usual at present emphasize that the prognosis apart from the histological structure decisively depends on the stage of tumour at the beginning of the treatment. Nothing has changed in this respect. Under the treatment mentioned of the carriers of metastasized tumours 28% survival who had no chance before this. Compared with that the survival rate of patients free from metastases is 81%. A differentiation between regional metastases, progressed subdiaphragmatic metastases and metastases distant from the primary tumour may contribute to the prognostic judgment.
对69例接受目前常用的扩大手术及细胞抑制治疗的睾丸畸胎瘤患者的检查强调，除组织学结构外，预后决定性地取决于治疗开始时肿瘤的分期。在这方面没有变化。在上述治疗下，转移性肿瘤携带者的生存率为28%，而在此之前他们没有生存机会。相比之下，无转移患者的生存率为81%。区分区域转移、进展性膈下转移和远离原发肿瘤的转移可能有助于预后判断。
